Literature DB >> 6072311

Pneumonic plague in an untreated plague-vaccinated individual.

R J Cohen, J L Stockard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6072311

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

1.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

2.  Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.

Authors:  R Colby Layton; Trevor Brasel; Andrew Gigliotti; Edward Barr; Steven Storch; Leslie Myers; Charles Hobbs; Frederick Koster
Journal:  J Med Primatol       Date:  2010-08-16       Impact factor: 0.667

3.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 4.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

5.  Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.

Authors:  Arnold Louie; Brian Vanscoy; Weiguo Liu; Robert Kulawy; David Brown; Henry S Heine; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

6.  Milestones in progression of primary pneumonic plague in cynomolgus macaques.

Authors:  Frederick Koster; David S Perlin; Steven Park; Trevor Brasel; Andrew Gigliotti; Edward Barr; Leslie Myers; Robert C Layton; Robert Sherwood; C R Lyons
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 7.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1968-07       Impact factor: 2.401

8.  Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Authors:  A Louie; H S Heine; B VanScoy; A Eichas; K Files; S Fikes; D L Brown; W Liu; M Kinzig-Schippers; F Sörgel; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 9.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine.

Authors:  Joanne Huang; Ajit J D'Souza; Jason B Alarcon; John A Mikszta; Brandi M Ford; Matthew S Ferriter; Michelle Evans; Todd Stewart; Kei Amemiya; Robert G Ulrich; Vincent J Sullivan
Journal:  Clin Vaccine Immunol       Date:  2009-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.